Target intelligence / Profile preview

Glutamate receptor, ionotropic, NMDA-type – redox site (NMDAR redox site)

Target
NMDAR redox site
Molecular classification
Ionotropic glutamate receptor, Ligand-gated ion channel, NMDA receptor
01

Overview

The NMDA receptor redox site is a critical allosteric regulatory region located on the extracellular domains of the N-methyl-D-aspartate (NMDA) receptor, primarily involving specific cysteine residues on the GluN1 and GluN2A subunits (Choi et al., 2000). This site functions as a molecular sensor for the cellular redox environment; the oxidation of these cysteine residues to form disulfide bridges or their S-nitrosylation decreases the receptor's open-channel probability and calcium conductance, whereas their reduction enhances receptor activity (Aizenman et al., 1989). In pathological states such as ischemic stroke, traumatic brain injury, and epilepsy, excessive reduction of this site can lead to NMDA receptor overactivation, resulting in excitotoxicity and neuronal death (Sanchez et al., 2000). Conversely, pharmacological modulation of the redox site using mild oxidants or S-nitrosylating agents, such as NitroMemantine, offers a therapeutic pathway to dampen pathological NMDAR activity while sparing the receptor's essential roles in synaptic plasticity and cognitive function (Lipton et al., 2015). This site represents a promising target for neuroprotective drugs that aim to achieve a finesse blockade of the receptor compared to traditional pore-blocking antagonists.

Other names
NMDA receptor redox modulatory siteNMDAR redox siteRedox-sensitive site of the NMDA receptorNMDAR sulfhydryl site
02

Mechanism of action

Redox modulation of the NMDA receptor involves the reversible oxidation and reduction of specific cysteine residues (e.g., Cys744 and Cys798 on GluN1, Cys399 on GluN2A) located on the extracellular domains. Oxidation of these sulfhydryl groups to form disulfide bonds or their modification via S-nitrosylation induces a conformational change that decreases the frequency of channel opening and reduces calcium influx. Conversely, reduction of these disulfide bonds by reducing agents increases the receptor's open-channel probability, enhancing excitatory currents and potentially leading to excitotoxic neuronal injury.

03

Biological functions

Regulation of NMDA receptor activitySynaptic plasticityLong-term potentiation (LTP)Neuronal signalingNeuroprotectionExcitotoxicity
04

Disease associations

EpilepsyIschemic strokeAlzheimer's diseaseSchizophreniaTraumatic brain injuryParkinson's diseaseAging-related cognitive decline
05

Safety considerations

Potential for cognitive impairment or memory deficits due to inhibition of physiological LTPOff-target effects from non-specific systemic redox modulationRisk of exacerbating excitotoxicity if the site is inadvertently reduced
06

Interacting drugs

NitroMemantine (YQW-036)

7 more in the full profile.

07

Biomarkers

S-nitrosylation of GluN2A subunitsGlutathione (GSH) to GSSG ratioNMDAR-mediated excitatory postsynaptic currents (EPSCs)Reactive oxygen species (ROS) levelsOxidative stress markers (e.g., malondialdehyde)

Beyond the preview

Go deeper on Glutamate receptor, ionotropic, NMDA-type – redox site (NMDAR redox site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor, ionotropic, NMDA-type – redox site (NMDAR redox site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call